Reduction of dermal scarring

Details for Australian Patent Application No. 2004293474 (hide)

Owner Canji, Inc.

Inventors Zepeda, Monica; Gu, Danling

Agent Griffith Hack

Pub. Number AU-B-2004293474

PCT Pub. Number WO2005/051971

Priority 60/524,993 24.11.03 US

Filing date 23 November 2004

Wipo publication date 9 June 2005

Acceptance publication date 23 December 2010

International Classifications

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C12N 15/861 (2006.01) Mutation or genetic engineering - Adenoviral vectors

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/051971 Priority application(s): WO2005/051971

23 December 2010 Application Accepted

  Published as AU-B-2004293474

21 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004293477-Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof

2004293471-Mutated anti-CD22 antibodies and immunoconjugates